amitriptyline has been researched along with Thromboembolism in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meier-Ewert, K | 1 |
| Baumgart, HH | 1 |
| Friedenberg, P | 1 |
| Thomassen, R | 1 |
| Vandenbroucke, JP | 1 |
| Rosendaal, FR | 1 |
2 other studies available for amitriptyline and Thromboembolism
| Article | Year |
|---|---|
[Thromboembolism complications in neuro- and thymoleptic therapy].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Chlorpromazine; Depression; Female; Humans; | 1967 |
Antipsychotic drugs and venous thromboembolism.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; | 2000 |